[1] 巫建康,陈燕.慢性阻塞性肺疾病的新定义及临床诊疗建议——基于2022年《柳叶刀》文件解读[J].中国全科医学,2023,26(2):127-133.
[2] 陈杰,王志杰,张旭旭,等.慢性阻塞性肺疾病患者急性加重期病原体分布特点及耐药性分析[J].华南预防医学,2023,49(2):249-251,255.
[3] Vogelmeier CF, Román-Rodríguez M, Singh D, et al. Goals of COPD treatment: Focus on symptoms and exacerbations[J]. Respir Med, 2020, 166(06):105938.
[4] 曹新西,徐晨婕,侯亚冰,等.1990—2025年我国高发慢性病的流行趋势及预测[J].中国慢性病预防与控制,2020,28(1):14-19.
[5] 吉为平,张双美,赵宏,等.慢性阻塞性肺疾病急性加重期合并侵袭性肺部真菌感染的病原菌特征及危险因素[J].中华医院感染学杂志,2022,32(13):1965-1968.
[6] 余来顺,谢守宁,妥亚军,等.COPD患者肺部感染的病原学及多药耐药铜绿假单胞菌感染危险因素[J].中华医院感染学杂志,2021,31(18):2759-2762.
[7] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组,中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志,2021,44(3):170-205.
[8] Humphries R, Bobenchik AM, Hindler JA, et al.Overview of changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition[J]. J Clin Microbiol, 2021, 59(12):e0021321.
[9] Wang C, Xu J, Yang L, et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): A national cross-sectional study[J]. Lancet, 2018, 391(10131):1706-1717.
[10] Grahn K, Gustavsson P, Andersson T, et al.Occupational exposure to particles and increased risk of developing chronic obstructive pulmonary disease (COPD): A population-based cohort study in Stockholm, Sweden[J]. Environ Res,2021, 200(5):111739.
[11] 丁巍,王文艺,邬超,等.慢性阻塞性肺疾病肺感染患者血清细胞因子及肺功能指标变化情况[J].华南预防医学,2020,46(5):586-588,592.
[12] Moghoofei M, Azimzadeh Jamalkandi S, Moein M, et al.Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis[J]. Infection, 2020, 48(1):19-35.
[13] Mussema A, Beyene G, Gashaw M.Bacterial isolates and antibacterial resistance patterns in a patient with acute exacerbation of chronic obstructive pulmonary disease in a tertiary teaching hospital, southwest Ethiopia[J]. Can J Infect Dis Med Microbiol, 2022, 2022(8):9709253.
[14] 高锋,马肖龙,吕家瑜.慢性阻塞性肺疾病急性加重期患者肺部感染的病原菌及危险因素分析[J].中国现代医学杂志,2021,31(12):18-22.
[15] 肖海励,魏海霞,张胜勇,等.慢性阻塞性肺疾病合并肺部感染患者病原菌分布及影响因素分析[J].中国病原生物学杂志,2022,17(11):1324-1327,1332.
[16] 王姣,郭亚君.慢性阻塞性肺疾病急性加重期合并肺部感染病原学及其预后评估[J].中华医院感染学杂志,2021,31(10):1522-1526.
[17] 吴雪红,汪旭明.297例慢性阻塞性肺疾病患者痰中病原菌分布及耐药性分析[J].现代预防医学,2018,45(18):3397-3400.
[18] 陈晨,周俊英,李一荣,等.耐碳青霉烯类肠杆菌科细菌的耐药基因及同源性分析[J].分子诊断与治疗杂志,2021,13(5):683-686. |
